{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:43:58Z","timestamp":1787838238157,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institute of Health","doi-asserted-by":"publisher","award":["NS047198"],"award-info":[{"award-number":["NS047198"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroscience Methods"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jneumeth.2015.03.028","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T12:59:31Z","timestamp":1428238771000},"page":"7-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Use of radiolabeled antagonist assays for assessing agonism at D2 and D3 dopamine receptors: Comparison with functional GTP\u03b3S assays"],"prefix":"10.1016","volume":"248","author":[{"given":"Juan","family":"Zhen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solav","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Neve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloke K.","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten E.A.","family":"Reith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneumeth.2015.03.028_bib0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1081\/RRS-200029953","article-title":"Signaling mechanisms of the D3 dopamine receptor","volume":"24","author":"Ahlgren-Beckendorf","year":"2004","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0014-2999(99)00653-6","article-title":"Agonist-induced GTPgamma35S binding mediated by human 5-HT(2C) receptors expressed in human embryonic kidney 293 cells","volume":"383","author":"Alberts","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jmb.2008.06.084","article-title":"Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors","volume":"382","author":"Bhattacharya","year":"2008","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(91)91456-B","article-title":"Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA","volume":"564","author":"Bouthenet","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0025","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1016\/j.bmc.2009.04.031","article-title":"Investigation of various N-heterocyclic substituted piperazine versions of 5\/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthale n-2-ol: effect on affinity and selectivity for dopamine D3 receptor","volume":"17","author":"Brown","year":"2009","journal-title":"Bioorgan Med Chem"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0030","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0026-895X(25)09903-1","article-title":"Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors","volume":"45","author":"Chio","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0040","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrd2082","article-title":"Drug-target residence time and its implications for lead optimization","volume":"5","author":"Copeland","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.sbi.2011.06.002","article-title":"Structural insights into agonist-induced activation of G-protein-coupled receptors","volume":"21","author":"Deupi","year":"2011","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0050","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0026-895X(25)14182-5","article-title":"The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium","volume":"28","author":"Ehlert","year":"1985","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0055","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1124\/mol.105.020685","article-title":"The two-state dimer receptor model: a general model for receptor dimers","volume":"69","author":"Franco","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0022-3565(25)38490-9","article-title":"Expression and pharmacological characterization of the human D3 dopamine receptor","volume":"268","author":"Freedman","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0065","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1021\/jm901618d","volume":"53","author":"Ghosh","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0070","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1021\/jm901184n","article-title":"Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydro benzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal models","volume":"53","author":"Ghosh","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0075","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/cmdc.201100140","article-title":"Dopamine D(2)\/D(3) agonists with potent iron chelation, antioxidant and neuroprotective properties: potential implication in symptomatic and neuroprotective treatment of Parkinson's disease","volume":"6","author":"Gogoi","year":"2011","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0080","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2174\/092986709787581851","article-title":"Agonist-trafficking and hallucinogens","volume":"16","author":"Gonzalez-Maeso","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0085","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/j.1471-4159.1985.tb07189.x","article-title":"Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide","volume":"44","author":"Grigoriadis","year":"1985","journal-title":"J Neurochem"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-642-25758-2_7","article-title":"The role of dopamine D(3) receptors in antipsychotic activity and cognitive functions","volume":"213","author":"Gross","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0095","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35075076","article-title":"BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization","volume":"411","author":"Guillin","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainresrev.2004.12.033","article-title":"The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence","volume":"49","author":"Heidbreder","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00210-008-0333-4","article-title":"Activation of G proteins and extracellular signal-regulated kinase 1\/2 phosphorylation via human dopamine D4.4 receptors: differential pathway-dependent potencies of receptor agonists","volume":"379","author":"Heusler","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0110","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.tibs.2009.07.005","article-title":"G protein-coupled receptor at work: the rhodopsin model","volume":"34","author":"Hofmann","year":"2009","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-079X.2004.00190.x","article-title":"Effects of temperature on 2-[125I]-iodomelatonin binding to melatonin receptors in the neural retina of the frog Rana perezi","volume":"38","author":"Isorna","year":"2005","journal-title":"J Pineal Res"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0120","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1021\/jm300268s","volume":"55","author":"Johnson","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0163-7258(01)00139-5","article-title":"Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs","volume":"90","author":"Joyce","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0130","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0165-6147(97)01136-X","article-title":"Differences between natural and recombinant G protein-coupled receptor systems with varying receptor\/G protein stoichiometry","volume":"18","author":"Kenakin","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0026-895X(25)14062-5","article-title":"A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data","volume":"17","author":"Kent","year":"1980","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00210-012-0811-6","volume":"386","author":"Kuzhikandathil","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0145","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0026-895X(25)08938-2","article-title":"Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities","volume":"42","author":"Lahti","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/jpet.107.134296","article-title":"G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors","volume":"325","author":"Lane","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0155","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nature10136","article-title":"Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation","volume":"474","author":"Lebon","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-6147(00)88989-0","article-title":"The two-state model of receptor activation","volume":"16","author":"Leff","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0165","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/jnr.22405","article-title":"Novel D3 dopamine receptor-preferring agonist D-264: evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin","volume":"88","author":"Li","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0170","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/mi.4.6.6","article-title":"The receptor concept: a continuing evolution","volume":"4","author":"Limbird","year":"2004","journal-title":"Mol Interventions"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.schres.2007.11.041","article-title":"The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: an association study and a large meta-analysis","volume":"101","author":"Ma","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0180","first-page":"357","article-title":"Central G-Protein coupled receptors (GPCR)s as molecular targets for the treatment of obesity: assets, liabilities and development status","volume":"3","author":"Miller","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10799898809049010","article-title":"An exact correction to the Cheng\u2013Prusoff correction","volume":"8","author":"Munson","year":"1988","journal-title":"J Recept Res"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0190","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0026-895X(24)12183-9","article-title":"G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: a guanosine-5\u2032-O-(3-[35S]thio)-triphosphate binding and antibody study","volume":"55","author":"Newman-Tancredi","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0195","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bcp.2012.06.023","article-title":"Medication discovery for addiction: translating the dopamine D3 receptor hypothesis","volume":"84","author":"Newman","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0200","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.neuropharm.2004.06.010","article-title":"The influence of G protein subtype on agonist action at D2 dopamine receptors","volume":"47","author":"Nickolls","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0205","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1016\/0006-2952(86)90496-X","article-title":"The dopamine D1 receptor: partial purification of a digitonin-solubilized receptor-guanine nucleotide binding complex","volume":"35","author":"Niznik","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(97)00251-6","article-title":"Agonist-induced [35S]GTPgammaS binding in the membranes of Spodoptera frugiperda insect cells expressing the human D3 dopamine receptor","volume":"226","author":"Pregenzer","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0215","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1016\/S0021-9258(18)53442-6","article-title":"A mutation-induced activated state of the beta 2-adrenergic receptor, extending the ternary complex model","volume":"268","author":"Samama","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0220","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/cn400106n","article-title":"D-512 and D-440 as novel multifunctional dopamine agonists: characterization of neuroprotection properties and evaluation of in vivo efficacy in a Parkinson's Disease Animal Model","volume":"10","author":"Santra","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00002826-199308000-00002","article-title":"Dopamine D3 receptor: basic and clinical aspects","volume":"16","author":"Schwartz","year":"1993","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0230","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0235","doi-asserted-by":"crossref","first-page":"15485","DOI":"10.1074\/jbc.270.26.15485","article-title":"Porcine m2 muscarinic acetylcholine receptor-effector coupling in Chinese hamster ovary cells","volume":"270","author":"Vogel","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-2999(93)91012-C","article-title":"Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligands","volume":"239","author":"Watts","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0245","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0026-895X(25)09399-X","article-title":"Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors","volume":"50","author":"Watts","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0250","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/jtbi.2000.2227","article-title":"Uncovering biases in high throughput screens of G-protein coupled receptors","volume":"208","author":"Woolf","year":"2001","journal-title":"J Theor Biol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0255","doi-asserted-by":"crossref","first-page":"9501","DOI":"10.1073\/pnas.0811437106","article-title":"The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex","volume":"106","author":"Yao","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0260","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/sj.bjp.0702905","article-title":"Efficient functional coupling of the human D3 dopamine receptor to G(o) subtype of G proteins in SH-SY5Y cells","volume":"128","author":"Zaworski","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0265","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/mol.106.025346","article-title":"Mutagenesis within helix 6 of the human beta1-adrenergic receptor identifies Lysine324 as a residue involved in imparting the high-affinity binding state of agonists","volume":"70","author":"Zeitoun","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jneumeth.2015.03.028_bib0270","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jneumeth.2010.01.031","article-title":"Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]spiperone binding to D2 and D3 dopamine receptors","volume":"188","author":"Zhen","year":"2010","journal-title":"J Neurosci Methods"}],"container-title":["Journal of Neuroscience Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027015001235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027015001235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:36:06Z","timestamp":1759019766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165027015001235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":54,"alternative-id":["S0165027015001235"],"URL":"https:\/\/doi.org\/10.1016\/j.jneumeth.2015.03.028","relation":{},"ISSN":["0165-0270"],"issn-type":[{"value":"0165-0270","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of radiolabeled antagonist assays for assessing agonism at D2 and D3 dopamine receptors: Comparison with functional GTP\u03b3S assays","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroscience Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneumeth.2015.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}